ATE23270T1 - Immunglobulin und fibronektin enthaltende pharmazeutische zusammensetzung. - Google Patents

Immunglobulin und fibronektin enthaltende pharmazeutische zusammensetzung.

Info

Publication number
ATE23270T1
ATE23270T1 AT83105957T AT83105957T ATE23270T1 AT E23270 T1 ATE23270 T1 AT E23270T1 AT 83105957 T AT83105957 T AT 83105957T AT 83105957 T AT83105957 T AT 83105957T AT E23270 T1 ATE23270 T1 AT E23270T1
Authority
AT
Austria
Prior art keywords
fibronectin
pharmaceutical composition
composition containing
containing immunoglobulin
produce
Prior art date
Application number
AT83105957T
Other languages
English (en)
Inventor
John L Lundblad
Miriam D Budinger
Richard S Schwartz
Original Assignee
Miles Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Lab filed Critical Miles Lab
Application granted granted Critical
Publication of ATE23270T1 publication Critical patent/ATE23270T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT83105957T 1982-07-02 1983-06-18 Immunglobulin und fibronektin enthaltende pharmazeutische zusammensetzung. ATE23270T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/394,977 US4412990A (en) 1982-07-02 1982-07-02 Composition having enhanced opsonic activity
EP83105957A EP0098431B1 (de) 1982-07-02 1983-06-18 Immunglobulin und Fibronektin enthaltende pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE23270T1 true ATE23270T1 (de) 1986-11-15

Family

ID=23561169

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83105957T ATE23270T1 (de) 1982-07-02 1983-06-18 Immunglobulin und fibronektin enthaltende pharmazeutische zusammensetzung.

Country Status (7)

Country Link
US (1) US4412990A (de)
EP (1) EP0098431B1 (de)
JP (1) JPS5920229A (de)
AT (1) ATE23270T1 (de)
CA (1) CA1208555A (de)
DE (1) DE3367328D1 (de)
ES (1) ES8504462A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001505A1 (en) * 1982-10-21 1984-04-26 Minneapolis Med Res Opsonins in peritoneal dialysis
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US7238668B1 (en) * 1989-09-01 2007-07-03 Fred Hutchinson Cancer Research Center Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof
US20080139789A1 (en) * 1990-10-22 2008-06-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
EP0680337A4 (de) * 1993-01-12 1997-07-30 Anthony George Gristina Methoden und zusammensetzungen zur direkter konzentrierter verabreichung passiver immunität.
AU734196B2 (en) * 1996-03-28 2001-06-07 Whitehead Institute Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US9522951B2 (en) 2011-10-31 2016-12-20 Bristol-Myers Squibb Company Fibronectin binding domains with reduced immunogenicity
EP3068867B1 (de) 2013-11-16 2018-04-18 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (de) 2014-09-26 2021-03-24 Terumo BCT, Inc. Geplante fütterung
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions

Also Published As

Publication number Publication date
DE3367328D1 (en) 1986-12-11
EP0098431A2 (de) 1984-01-18
EP0098431B1 (de) 1986-11-05
ES523795A0 (es) 1985-04-16
CA1208555A (en) 1986-07-29
EP0098431A3 (en) 1984-09-12
JPH0585525B2 (de) 1993-12-07
JPS5920229A (ja) 1984-02-01
US4412990A (en) 1983-11-01
ES8504462A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
DE3367328D1 (en) Pharmaceutical composition comprising immune globulin and fibronectin
IL103981A0 (en) Pharmaceutical compositions for treatment of multiple sclerosis
NL300156I1 (nl) Therapeutische toepassing van chimere en radioactief gemerkte antilichamen tegen humane B-Lymfocyt beperkt differentiatie antigeen voor de behandelingvan B-Cel lymfoom.
GB2071670B (en) Nutrient compositions and methods of administering the same
DK0663825T3 (da) Anvendelse af melatonin i orale doser til fremkaldelse af søvn
GB1534823A (en) Dental chairs or like patient supporting devices
ZA938466B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentation antigen for treatment of B cell lymphoma
NL192564B (nl) Inrichting voor het toedienen van medicamenten aan patiënten.
IT1175268B (it) Dispositivo ad uso dei fumatori per prevenire l'inalazione di catrami ed altri prodotti nocivi
PT78320A (de) System und tabakerzeugnis zur selbstverfertigung von zigaretten durch den verbraucher
ATE66808T1 (de) Zellstimulierendes mittel.
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
ATE50143T1 (de) Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
IL75805A (en) Pharmaceutical immunosuppressor compositions containing lycorine
ES432848A2 (es) Procedimiento para la obtencion de derivados de alcanolami- na.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
LU81253A1 (fr) Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant
JPS56169621A (en) Perfume and fragrance made of di-and tetrahydrobenzofuranone derivative
FI883723A7 (fi) Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
IT1199619B (it) Vernici additivate
SE8306384D0 (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee